Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 49 is a non-functional, non-coding genetic element located in the genome with high sequence homology to the canonical 5S ribosomal RNA gene[2][4]. Unlike functional 5S rRNA genes, which form an essential structural and functional part of the large ribosomal subunit across all life domains[1][3][5], pseudogenes such as RNA5SP49 have lost their capacity to produce active 5S rRNA due to deletions, insertions, or other mutations[4][6]. Pseudogenes generally do not encode proteins or functional RNAs, and are not considered therapeutic targets, receptors, enzymes, or transporters[2][4][6]. In rare cases, pseudogene transcripts can participate in post-transcriptional regulation through mechanisms such as RNA interference or miRNA sponging, but specific evidence for disease involvement or biomarker utility for 5S ribosomal pseudogenes is lacking[4]. The presence of "pseudogene" in the name indicates this target is non-functional and not a therapeutic target. It is generally not considered biologically relevant in terms of classical pharmacology or drug development[2][4][6]. There is no established interaction with drugs or use in clinical decision-making. This entry is not appropriate as a therapeutic target because it is a non-coding pseudogene, not a receptor, enzyme, or other relevant molecule for drug targeting[2][4][6]. No known drugs, mechanisms of action, biomarker status, or safety concerns are associated. The entry may be misspecified if intended for biological or therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 49 (RNA5SP49).